Malta vs Saint Vincent and the Grenadines: HIV-positive TB patients on ART (antiretroviral therapy)
Malta
100.0%
in 2023
Saint Vincent and the Grenadines
100.0%
in 2023
Malta rank
1st
Saint Vincent and the Grenadines rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Malta
- Saint Vincent and the Grenadines
How they compare
Malta currently reports 100.0% against 100.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 1 time across 7 shared years of data; in 2006 it was Malta ahead.
Malta ranks 1st and Saint Vincent and the Grenadines ranks 1st of 144 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 48.0% | 52.0% | Malta |
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malta or Saint Vincent and the Grenadines?
- Malta, at 100.0% against 100.0% in Saint Vincent and the Grenadines as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malta and Saint Vincent and the Grenadines?
- 0.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Saint Vincent and the Grenadines?
- 7 years are reported by both, from 2006 to 2023.
- How do Malta and Saint Vincent and the Grenadines rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Malta ranks 1st and Saint Vincent and the Grenadines ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.